Variant report
Variant | nsv1029601 |
---|---|
Chromosome Location | chr6:62503830-62548780 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:62545749..62547961-chr6:62548535..62550868,2 | MCF-7 | breast: | |
2 | chr6:62520772..62522597-chr6:62523953..62526303,2 | K562 | blood: | |
3 | chr6:62545749..62547961-chr6:62548535..62550868,2 | MCF-7 | breast: | |
4 | chr6:62520772..62522597-chr6:62523953..62526303,2 | K562 | blood: | |
5 | chr6:62519001..62519629-chr6:62859955..62860555,3 | MCF-7 | breast: | |
6 | chr6:62518763..62519292-chr6:62993656..62994388,2 | MCF-7 | breast: | |
7 | chr6:62518549..62519303-chr6:63600674..63601315,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191397439 | chr6:62510602-62510603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561945620 | chr6:62510654-62510655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183188432 | chr6:62510707-62510708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540990994 | chr6:62510710-62510711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539705514 | chr6:62510835-62510836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146749277 | chr6:62510903-62510904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1743449 | chr6:62510920-62510921 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs140252006 | chr6:62510925-62510926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76285305 | chr6:62510937-62510938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561317841 | chr6:62510983-62510984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531721859 | chr6:62510985-62510986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139765454 | chr6:62520019-62520020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143429044 | chr6:62520020-62520021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573255163 | chr6:62520037-62520038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184208659 | chr6:62520080-62520081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576016195 | chr6:62520102-62520103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1743457 | chr6:62520127-62520128 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs189083673 | chr6:62520130-62520131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181255123 | chr6:62520165-62520166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559970224 | chr6:62521842-62521843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192467790 | chr6:62521885-62521886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546942758 | chr6:62521922-62521923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184855606 | chr6:62521981-62521982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529320140 | chr6:62522043-62522044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373231062 | chr6:62522075-62522076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374939427 | chr6:62522111-62522112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533059598 | chr6:62522144-62522145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551084934 | chr6:62522146-62522147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188845097 | chr6:62522212-62522213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs193186743 | chr6:62522214-62522215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552011340 | chr6:62522223-62522224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567136090 | chr6:62522232-62522233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544832582 | chr6:62522236-62522237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73476635 | chr6:62522238-62522239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9453107 | chr6:62522251-62522252 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs563190980 | chr6:62522261-62522262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369354194 | chr6:62522298-62522299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537890715 | chr6:62522324-62522325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555840157 | chr6:62522331-62522332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530707564 | chr6:62522389-62522390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531947434 | chr6:62522405-62522406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544766696 | chr6:62522449-62522450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs376954441 | chr6:62522505-62522506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140145763 | chr6:62522561-62522562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572231583 | chr6:62522571-62522572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs372940941 | chr6:62522618-62522619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534307939 | chr6:62522657-62522658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548901177 | chr6:62522659-62522660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs542539771 | chr6:62522664-62522665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115166884 | chr6:62522672-62522673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung cancer | 19547694 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 19492091 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:62510600-62511000 | Enhancers | Fetal Heart | heart |
2 | chr6:62520000-62520200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr6:62521800-62574000 | Weak transcription | Primary B cells from cord blood | blood |
4 | chr6:62524200-62524800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr6:62524400-62525000 | Enhancers | Primary hematopoietic stem cells | blood |
6 | chr6:62524600-62525600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
7 | chr6:62524600-62526200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr6:62524800-62525800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr6:62525000-62525400 | Flanking Active TSS | Primary hematopoietic stem cells | blood |
10 | chr6:62525400-62525800 | Enhancers | Primary hematopoietic stem cells | blood |
11 | chr6:62525800-62526400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr6:62526400-62531200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr6:62529600-62530000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr6:62530000-62534200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr6:62531200-62531400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr6:62534200-62534400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr6:62534400-62536200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr6:62536200-62536600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr6:62543200-62545400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
20 | chr6:62543800-62545200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
21 | chr6:62543800-62545400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
22 | chr6:62545400-62545800 | Enhancers | Fetal Brain Male | brain |